Brand name
E.E.S. Granules, the original
We didn’t find a savings card or cash price from E.E.S. Granules’s maker. Ask the pharmacy for E.E.S. Granules’s cash price. With insurance, ask what your plan charges.
Generic name: erythromycin ethylsuccinate
Used for: Respiratory infections · Skin infections · Sexually transmitted infections · Whooping cough (pertussis) · Preventing rheumatic fever · Diphtheria · Amebic infection of the intestines (amebiasis) · Listeria infection (listeriosis) · 7 more
Ask for the cash price
Generic erythromycin ethylsuccinate
No pharmacy we check posts a price for it.
A regular generic has the same active ingredient as E.E.S. Granules, and the FDA requires it to work the same way.
E.E.S. Granules, the original
We didn’t find a savings card or cash price from E.E.S. Granules’s maker. Ask the pharmacy for E.E.S. Granules’s cash price. With insurance, ask what your plan charges.
The same medicine as E.E.S. Granules, without the brand name
The same medicine as E.E.S. Granules, without the brand name. Its NDC is the number that names the exact product: give it to the pharmacy and they can look it up or order it.
erythromycin ethylsuccinate
Give the pharmacy this NDC
What to say at the pharmacy
“Before you fill my E.E.S. Granules, can you tell me what I’d pay for the brand, for the authorized generic from Wilshire Pharmaceuticals (NDC 52536-134-13), and for a regular generic?”
Paying cash? Ask for each one’s cash price. With insurance, ask what your plan charges for each.
Source: FDA, updated November 16, 2026
Official labels and ingredient lists from DailyMed (U.S. National Library of Medicine).
Same active and inactive ingredients as E.E.S. Granules.
Active: erythromycin ethylsuccinate 200 mg/5 mL
Inactive, on both labels:
Same active ingredient as E.E.S. Granules. Fillers and dyes can differ.
Generic erythromycin ethylsuccinate is sold. Ask the pharmacy for its cash price. With insurance, ask what your plan charges.
To reduce the development of drug-resistant bacteria and maintain the effectiveness of E.E.S. and other antibacterial drugs, E.E.S. should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
E.E.S. is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the diseases listed below:
Upper respiratory tract infections of mild to moderate degree caused by Streptococcus pyogenes, Streptococcus pneumoniae,or Haemophilus influenzae(when used concomitantly with adequate doses of sulfonamides, since many strains of H. influenzaeare not susceptible to the erythromycin concentrations ordinarily achieved). (See appropriate sulfonamide labeling for prescribing information.)
Lower-respiratory tract infections of mild to moderate severity caused by Streptococcus pneumoniaeor Streptococcus pyogenes.
Listeriosis caused by Listeria monocytogenes.
Pertussis (whooping cough) caused by Bordetella pertussis. Erythromycin is effective in eliminating the organism from the nasopharynx of infected individuals rendering them noninfectious. Some clinical studies suggest that erythromycin may be helpful in the prophylaxis of pertussis in exposed susceptible individuals.
Respiratory tract infections due to Mycoplasma pneumoniae.
Skin and skin structure infections of mild to moderate severity caused by Streptococcus pyogenesor Staphylococcus aureus(resistant staphylococci may emerge during treatment).
Diphtheria: Infections due to Corynebacterium diphtheriae, as an adjunct to antitoxin, to prevent establishment of carriers and to eradicate the organism in carriers.
Erythrasma: In the treatment of infections due to Corynebacterium minutissimum.
Intestinal amebiasis caused by Entamoeba histolytica(oral erythromycins only). Extraenteric amebiasis requires treatment with other agents.
Acute pelvic inflammatory disease caused by Neisseria gonorrhoeae: As an alternative drug in treatment of acute pelvic inflammatory disease caused by N. gonorrhoeaein female patients with a history of sensitivity to penicillin. Patients should have a serologic test for syphilis before receiving erythromycin as treatment of gonorrhea and a follow-up serologic test for syphilis after 3 months.
Syphilis caused by Treponema pallidum: Erythromycin is an alternate choice of treatment for primary syphilis in patients allergic to the penicillins. In treatment of primary syphilis, spinal fluid examinations should be done before treatment and as part of follow-up after therapy.
Erythromycins are indicated for the treatment of the following infections caused by Chlamydia trachomatis: conjunctivitis of the newborn, pneumonia of infancy, and urogenital infections during pregnancy. When tetracyclines are contraindicated or not tolerated, erythromycin is indicated for the treatment of uncomplicated urethral, endocervical, or rectal infections in adults due to Chlamydia trachomatis.
When tetracyclines are contraindicated or not tolerated, erythromycin is indicated for the treatment of nongonococcal urethritis caused by Ureaplasma urealyticum.
Legionnaires' Disease caused by Legionella pneumophila: Although no controlled clinical efficacy studies have been conducted, in vitroand limited preliminary clinical data suggest that erythromycin may be effective in treating Legionnaires' Disease.
Prophylaxis
Prevention of Initial Attacks of Rheumatic Fever
Penicillin is considered by the American Heart Association to be the drug of choice in the prevention of initial attacks of rheumatic fever (treatment of Streptococcus pyogenesinfections of the upper respiratory tract, e.g., tonsillitis or pharyngitis). Erythromycin is indicated for the treatment of penicillin-allergic patients. 1The therapeutic dose should be administered for 10 days.
Prevention of Recurrent Attacks of Rheumatic Fever
Penicillin or sulfonamides are considered by the American Heart Association to be the drugs of choice in the prevention of recurrent attacks of rheumatic fever. In patients who are allergic to penicillin and sulfonamides, oral erythromycin is recommended by the American Heart Association in the long-term prophylaxis of streptococcal pharyngitis (for the prevention of recurrent attacks of rheumatic fever). 1
Source: the FDA label for E.e.s (Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)), December 16, 2023. Full label on DailyMed
Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/e-e-s-granules/